(Reuters) - The Food and Drug Administration's long-awaited guidelines for the sale of lower-cost versions of biotechnology drugs leave open the possibility that some products might not need to be tested in humans. The proposed rules, issued on Thursday, require studies showing that the generic copies are "highly similar" to the originals, but there are several ways that might be proven. Because of their complexity, generic copies of biotech drugs - first introduced in the 1980s - are known as "biosimilars." "We're trying to send the signal that it's not one-size-fits-all. ... read more..
Illicit Drugs Bought Off Internet May Be Poisons, Experts Warn
THURSDAY, Feb. 9 (HealthDay News) -- A case study of two men who were poisoned and turned blue after ingesting what they thought was a recreational drug that they had bought on the Internet highlights the dangers of such purchases, a new report claims. read more..
No comments:
Post a Comment